Clinical Trials for ProLynx

Explore 3 clinical trials worldwide

Showing 1-3 of 3 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: ProLynx

Clinical Trials (3)

NCT06894745
PET [89Zr]DFO-starPEG in Solid Tumors
PHASE1Recruiting
13 participants
Started: Jun 2, 2025 · Completed: Dec 31, 2027
3 conditions3 sponsors1 location
NCT06337630
A Study on Tuvusertib (Oral ATR Inhibitor) in Combination With PLX038 (Topo1 Inhibitor) in Patients With Advanced Solid Tumors
PHASE1Recruiting
92 participants
Started: Jan 20, 2025 · Completed: Sep 23, 2029
1 condition3 sponsors2 locations
NCT06162351
A Study to Evaluate the Efficacy and Toxicities of PLX038, in Patients With Locally Advanced or Metastatic Triple-negative Breast Cancer
PHASE2Recruiting
44 participants
Started: Apr 17, 2024 · Completed: Apr 17, 2027
2 conditions2 sponsors2 locations